[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626845":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":52,"collaborators":25,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":25,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":25,"enrollmentInfo":63,"targetDuration":25,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":39,"whyStopped":25,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":83},{"fullName":5,"class":6},"Ceragem Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Non-implantable neuromuscular electrical stimulation (NMES) group","EXPERIMENTAL","Non-implantable neuromuscular electrical stimulation (NMES) group for urinary incontinence",[13],"Device: Ceragem Innerfit medi-tech",{"label":15,"type":16,"description":17,"interventionNames":18},"Comparator device group","SHAM_COMPARATOR","Non-implantable neuromuscular electrical stimulation (NMES) without electrical stimulation group for urinary incontinence",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Ceragem Innerfit medi-tech","Stress Urinary Incontinence Device (Ceragem Innerfit medi-tech)\n\nThe investigational device and control device were applied at least 5 days per week, twice daily (morning and evening), for 15 minutes per session, over a total period of 12 weeks.",[15,9],null,[27],{"name":28,"affiliation":29,"role":30},"Kyu Sung Lee, MD","Samsung Seoul Hospital","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":25,"email":36},"Myeongbae Shin, Researcher","CONTACT","82-10-4373-2808","mbshin94@ceragem.com",[38],{"facility":29,"status":39,"city":40,"state":25,"zip":25,"country":41,"countryCode":25,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Seoul","South Korea",{"type":43,"coordinates":44},"Point",[45,46],126.9784,37.566,{"lat":46,"lon":45},[49],{"name":50,"role":34,"phone":51,"phoneExt":25,"email":25},"Kyu sung Lee, MD","82-2-3410-0200",{"type":53,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100626845","stress-urinary-incontinence-for-female-patients-cgm-muit-2301-100626845",false,"NCT07440927","Stress Urinary Incontinence for Female Patients (CGM MUIT-2301)","A Multi-center, Prospective, Randomized, Double-blind, Sham Device Controlled Clinical Trial to Compare and Evaluate the Efficacy and Safety of the Use an Investigational Device (Model Name CGM MUIT-2301) and Sham Device (Model Name CGM MUIT-2301C) for Female Patients With Stress Urinary Incontinence","Inclusion Criteria:\n\n* Patients with urine leakage of ≥1 g on the standardized pad test\n\nExclusion Criteria:\n\n* Patients with mixed urinary incontinence with predominant urgency urinary incontinence\n* Patients with stress urinary incontinence\n* Patients with overflow urinary incontinence","FEMALE","19 Years",{"count":64,"type":65},96,"ESTIMATED","INTERVENTIONAL",[68],"NA","This study is a multicenter, prospective, randomized, double-blind, sham-controlled clinical trial conducted in female patients with stress urinary incontinence.",[71],"Stress Urinary Incontinence (SUI)",[71],"2026-02-25",{"date":75,"type":76},"2026-02-27","ACTUAL",{"date":78,"type":76},"2024-12-13",{"date":80,"type":65},"2026-09-30",{"name":82,"class":6},"Ceragem Clinical Inc.",1]